Skip to main content
. 2022 Aug 11;37(9):1983–1995. doi: 10.1007/s00384-022-04228-1

Table 1.

Demographics and postoperative complication rate for colon cancer referred to body mass index

Underweight Normal weight Overweight Obesity Total
Patient population (n/(%)) 20 (3) 296 (43) 255 (37) 115 (17) 686 (100)
Age [year] 67 (31–94) 66 (25–96) 68 (31–90) 68 (31–87) 67 (25–96)
Gender (n/(%))
Male 4 (20) 134 (45) 159 (62) 70 (61) 367 (53)
Female 16 (80) 162 (55) 96 (38) 45 (39) 319 (47)
CCI (points/(%))
0 points 7 (35) 111 (38) 74 (29) 22 (19) 214 (31)
1–2 points 5 (25) 61 (21) 77 (30) 37 (32) 180 (26)
 > 2 points 8 (40) 124 (42) 104 (41) 56 (49) 292 (43)
ASA scorex (n/(%))
2 13 (65) 178 (63) 150 (62) 54 (49) 395 (59)
3 6 (30) 99 (35) 84 (35) 52 (47) 241 (36)
4 - 7 (2) 8 (3) 4 (4) 19 (3)
5 1 (5) - 1 (< 1) - 2 (< 1)
Localization (n/(%))
Ascending colon 12 (60) 146 (49) 113 (44) 55 (48) 326 (48)
Transverse colon 2 (10) 24 (8) 25 (10) 9 (8) 60 (9)
Descending colon 3 (15) 39 (13) 33 (13) 11 (10) 86 (13)
Sigmoid colon 3 (15) 87 (29) 84 (33) 40 (35) 214 (31)
UICC (n/(%))
Stage 0y - 10 (3) 4 (2) - 14 (2)
Stage I 2 (10) 45 (15) 52 (20) 23 (20) 122 (18)
Stage II 7 (35) 91 (31) 79 (31) 42 (37) 219 (32)
Stage III 4 (20) 64 (22) 60 (24) 21 (18) 149 (22)
Stage IV 7 (35) 85 (29) 60 (24) 29 (25) 181 (26)
Resection (n/(%))
Right hemicolectomy 12 (60) 151 (51) 120 (47) 56 (49) 339 (49)
Transverse colon resection 2 (10) 11 (4) 11 (4) 2 (2) 26 (4)
Left hemicolectomy 4 (20) 45 (15) 34 (13) 14 (12) 97 (14)
Sigmoid colon resection 1 (5) 63 (21) 57 (22) 34 (30) 155 (23)
Multisegmental resection 1 (5) 26 (9) 33 (13) 9 (8) 69 (10)
Approach (n/(%))
Open surgery 20 (100) 271 (92) 243 (95) 106 (92) 640 (93)
Laparoscopic surgery - 25 (8) 12 (5) 9 (8) 46 (7)
Bridge-to-surgery 2 (10) 18 (6) 11 (4) 6 (5) 37 (5)
Emergency surgery 3 (15) 27 (9) 17 (7) 10 (9) 57 (8)
Simultaneous HIPEC 1 (5) 14 (5) 8 (3) 1 (< 1) 24 (3)
Wound infection (n/(%))
Yes - 20 (6.8) 23 (9.0) 11 (9.6) 54 (7.9)
No 20 (100) 276 (93.2) 232 (91.0) 104 (90.4) 632 (92.1)
Level of wound infection (n/(%))
- 14 (4.7) 13 (5.1) 9 (7.8) 36 (66.7)
II° - 4 (1.4) - 1 (0.9) 5 (9.3)
III° - 1 (0.3) 4 (1.6) - 5 (9.3)
IV° - 1 (0.3) 5 (2.0) 1 (0.9) 7 (13.0)
- - 1 (0.4) - 1 (1.9)
VI° - - - - -
Total - 20 (6.8) 23 (9.0) 11 (9.6) 54 (7.9)
Anastomotic leakage (n/(%))
Yes - 10 (3.4) 8 (3.1) 4 (3.5) 22 (3.2)
No 20 (100) 286 (96.6) 247 (96.9) 111 (96.5) 664 (96.8)
Level of anastomotic leakage (n/(%))
- 1 (0.3) 1 (0.4) - 2 (9.1)
II° - - - - -
III° - - - - -
IV° - 7 (2.4) 3 (1.2) - 10 (45.5)
- 2 (0.7) 3 (1.2) 2 (0.9) 7 (31.8)
VI° - - 1 (0.4) 2 (0.9) 3 (13.6)
Total - 10 (3.4) 8 (3.1) 4 (3.5) 22 (100)
In-hospital mortality (n/(%))
sMOF 1 (5.0) 4 (1.4) 1 (0.4) 5 (4.3) 11 (39.3)
CV/CP 1 (5.0) 8 (2.7) 4 (1.6) 4 (3.5) 17 (60.7)
Total 2 (10.0) 12 (4.1) 5 (2.0) 9 (7.8) 28 (4.1)

CCI Charlson Comorbidity Index, ASA score American Society of Anesthesiologists, UICC Union for International Cancer Control, HIPEC hyperthermic intraperitoneal chemotherapy, sMOF septic multi-organ failure, CV/CP cardiovascular/cardiopulmonary conditional organ failure

xpercentages refer to 666 patients because it was undocumented in 31 patients

yUICC 0 was awarded for histopathological findings of a pTis